Fred Hutch Cancer Research

Seattle, Washington 98109

2 studies enrolling now · 4 studies all time

What they study most

Advanced CCNE1-amplified Solid Tumors, Advanced HR+/HER2- Breast Cancer, Chronic Myelogenous Leukemia - Chronic Phase, Extensive-stage Small Cell Lung Cancer, Metastatic Hormone-sensitive Prostate Cancer, Multiple Myeloma

Studies at this site

• Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors — Recruiting now
• An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) — Recruiting now
• PHE885 CAR-T Therapy in Adult Participants With Relapsed and Refractory Multiple Myeloma — Stopped early
• Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia — Running, not enrolling